Browse by Academic Unit (A-Z)

Export as [feed] Atom [feed] RSS
Group by: Creators Name | Item Type
Number of items at this level: 98.


Adams, WC, Chen, Y-H, Kratchmarov, R et al. (10 more authors) (2016) Anabolism-Associated Mitochondrial Stasis Driving Lymphocyte Differentiation over Self-Renewal. Cell Reports, 17 (12). pp. 3142-3152. ISSN 2211-1247

Agathanggelou, A, Smith, E, Davies, NJ et al. (20 more authors) (2017) USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status. Blood, 130 (2). pp. 156-166. ISSN 0006-4971

Al-Maskari, M, Care, MA, Robinson, E et al. (3 more authors) (2018) Site-1 protease function is essential for the generation of antibody secreting cells and reprogramming for secretory activity. Scientific Reports, 8. 14338. ISSN 2045-2322

Alaggio, R., Amador, C., Anagnostopoulos, I. et al. (307 more authors) (2023) Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748. Leukemia, 37 (9). pp. 1944-1951. ISSN 0887-6924

Appleby, N, Eyre, TA, Cabes, M et al. (7 more authors) (2019) The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease. BMC Cancer, 19 (1). 471. ISSN 1471-2407

Arumugakani, G, Stephenson, SJ, Newton, DJ et al. (5 more authors) (2017) Early emergence of CD19-negative human antibody secreting cells at the plasmablast to plasma cell transition. Journal of Immunology, 198 (12). pp. 4618-4628. ISSN 0022-1767

Barbarulo, A, Iansante, V, Chaidos, A et al. (7 more authors) (2013) Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma. Oncogene, 32 (36). pp. 4231-4242. ISSN 0950-9232

Barr, PM, Brown, JR, Hillmen, P et al. (19 more authors) (2017) Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL. Blood, 129 (19). pp. 2612-2615. ISSN 0006-4971

Barrientos, JC, Burger, JA, Byrd, JC et al. (5 more authors) (2019) Characterizing the kinetics of lymphocytosis in patients with chronic lymphocytic leukemia treated with single-agent ibrutinib. Leukemia & Lymphoma, 60 (4). pp. 1000-1005. ISSN 1042-8194

Barrientos, JC, O'Brien, S, Brown, JR et al. (25 more authors) (2018) Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Clinical Lymphoma Myeloma and Leukemia, 18 (12). 803-813.e7. ISSN 2152-2650

Bigley, V, Maisuria, S, Cytlak, U et al. (20 more authors) (2018) Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation. Journal of Allergy and Clinical Immunology, 141 (6). pp. 2234-2248. ISSN 0091-6749

Braga, FAV, Hertoghs, KML, Kragten, NAM et al. (16 more authors) (2015) The Blimp-1 homologue Hobit identifies effector-type lymphocytes in humans. European Journal of Immunology, 45 (10). 2945 - 2958. ISSN 0014-2980

Brown, JR, Hillmen, P, O'Brien, S et al. (27 more authors) (2018) Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE(TM) study in patients with previously treated CLL/SLL. Leukemia, 32. pp. 83-91. ISSN 0887-6924

Brown, JR, Moslehi, J, O' Brien, S et al. (24 more authors) (2017) Characterization Of Atrial Fibrillation Adverse Events Reported In Ibrutinib Randomized Controlled Registration Trials. Haematologica, 102 (10). pp. 1796-1805. ISSN 0390-6078

Bubici, C and Papa, S (2014) JNK signalling in cancer: in need of new, smarter therapeutic targets. British Journal of Pharmacology, 171 (1). pp. 24-37. ISSN 0007-1188

Bubici, C and Papa, S (2015) Starving cancer cells of sugar could be the key to future treatment. The Conversation.

Bubici, C and Papa, S (2019) The Warburg Effect Regulation Under Siege: the Intertwined Pathways in Health and Disease. Frontiers in Cell and Developmental Biology, 7. UNSP 80. ISSN 2296-634X

Buehler, A, Wendtner, C-M, Kipps, TJ et al. (17 more authors) (2016) Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial. Blood Cancer Journal, 6. ARTN e404. ISSN 2044-5385

Burger, JA, Tedeschi, A, Barr, PM et al. (31 more authors) (2015) Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. New England Journal of Medicine, 373 (25). pp. 2425-2437. ISSN 0028-4793

Care, MA, Stephenson, SJ, Barnes, NA et al. (7 more authors) (2016) Network analysis identifies proinflammatory plasma cell polarization for secretion of ISG15 in human autoimmunity. Journal of Immunology, 197 (4). pp. 1447-1459. ISSN 0022-1767

Care, MA, Westhead, DR and Tooze, RM (2015) Gene expression meta-analysis reveals immune response convergence on the IFNγ-STAT1-IRF1 axis and adaptive immune resistance mechanisms in lymphoma. Genome Medicine, 7. 96. ISSN 1756-994X

Care, MA, Westhead, DR and Tooze, RM (2019) Parsimonious Gene Correlation Network Analysis (PGCNA): a tool to define modular gene co-expression for refined molecular stratification in cancer. npj Systems Biology and Applications, 5. 13. ISSN 2056-7189

Chinen, T, Kannan, AK, Levine, AG et al. (7 more authors) (2016) An essential role for the IL-2 receptor in Treg cell function. Nature Immunology, 17 (11). pp. 1322-1333. ISSN 1529-2908

Davies, A, Cummin, TE, Barrans, S et al. (21 more authors) (2019) Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial. The Lancet Oncology, 20 (5). pp. 649-662. ISSN 1470-2045

Dennis, M, Culligan, D, Karamitros, D et al. (8 more authors) (2013) Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalities. Leukemia Research Reports, 2 (2). pp. 70-74. ISSN 2213-0489

El-Sherbiny, YM, Psarras, A, Yusof, MYM et al. (8 more authors) (2018) Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports, 8. ARTN 14846. ISSN 2045-2322

Filia, A, Droop, A, Harland, M et al. (10 more authors) (2019) High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material. Scientific Reports, 9 (1). ARTN: 8908. ISSN 2045-2322

Flinn, IW, Hillmen, P, Montillo, M et al. (22 more authors) (2018) The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL. Blood, 132 (23). pp. 2446-2455. ISSN 0006-4971

Gillespie, J, Ross, RL, Corinaldesi, C et al. (7 more authors) (2018) Transforming Growth Factor β Activation Primes Canonical Wnt Signaling Through Down-Regulation of Axin-2. Arthritis & Rheumatology, 70 (6). pp. 932-942. ISSN 2326-5191

Griffin, M, Hillmen, P, Munir, T et al. (4 more authors) (2019) Significant hemolysis is not required for thrombosis in paroxysmal nocturnal hemoglobinuria. Haematologica, 104 (3). e94-e96. ISSN 0390-6078

Grinberg-Bleyer, Y, Caron, R, Seeley, JJ et al. (5 more authors) (2018) The Alternative NF-κB Pathway in Regulatory T Cell Homeostasis and Suppressive Function. The Journal of Immunology, 200 (7). pp. 2362-2371. ISSN 0022-1767

Hall, K, Scott, KJ, Rose, A et al. (9 more authors) (2012) Reovirus-mediated cytotoxicity and enhancement of innate immune responses against acute myeloid leukemia. BioResearch Open Access, 1 (1). pp. 3-15. ISSN 2164-7844

Hillmen, P, Muus, P, Röth, A et al. (11 more authors) (2013) Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. British Journal of Haematology, 162 (1). pp. 62-73. ISSN 0007-1048

Holmes, KB, Sadreev, II, Rawstron, AC et al. (4 more authors) (2019) Ibrutinib induces chromatin reorganisation of chronic lymphocytic leukaemia cells. Oncogenesis, 8. 32. ISSN 2157-9024

Howard, DR, Munir, T, Hockaday, AM et al. (7 more authors) (2016) Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial. Trials, 17. 456. ISSN 1745-6215

Howard, DR, Munir, T, McParland, L et al. (12 more authors) (2017) Results of the randomized phase IIB ARCTIC trial of low dose Rituximab in previously untreated CLL. Leukemia, 31. pp. 2416-2425. ISSN 0887-6924

Hull, MA, Booth, JK, Tisbury, A et al. (4 more authors) (1999) Cyclooxigenase 2 is up-regulated and localized to macrophages in the intestine of Min mice. British Journal of Cancer, 79 (9-10). pp. 1399-1405. ISSN 0007-0920

Hurst, CD, Alder, O, Platt, FM et al. (15 more authors) (2017) Genomic Subtypes of Non-Invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency. Cancer Cell, 32 (5). pp. 701-715. ISSN 1535-6108

Kater, AP, Seymour, JF, Hillmen, P et al. (12 more authors) (2019) Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study. Journal of Clinical Oncology, 34 (4). pp. 269-277. ISSN 0732-183X

Kennedy, R and Klein, U (2018) Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies. Cells, 7 (11). ARTN 189. ISSN 2073-4409

Kirby, AC, Newton, DJ, Carding, SR et al. (1 more author) (2007) Evidence for the involvement of lung-specific γδ T cell subsets in local responses to Streptococcus pneumoniae infection. European Journal of Immunology, 37 (12). pp. 3404-3413. ISSN 0014-2980

Kreuz, S, Holmes, KB, Tooze, RM et al. (1 more author) (2015) Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas. Molecular Cancer, 14. 205. ISSN 1476-4598

Kwok, M, Davies, N, Agathanggelou, A et al. (12 more authors) (2016) ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells. Blood, 127 (5). pp. 582-595. ISSN 0006-4971

Kwok, M, Rawstron, AC, Varghese, A et al. (6 more authors) (2016) Minimal residual disease is an independent predictor for 10-year survival in CLL. Blood, 128 (24). pp. 2770-2773. ISSN 0006-4971

Lee, NCW, Carella, MA, Papa, S et al. (1 more author) (2018) High Expression of Glycolytic Genes in Cirrhosis Correlates With the Risk of Developing Liver Cancer. Frontiers in Cell and Developmental Biology, 6. 138. ISSN 2296-634X

Li, X, Gadzinsky, A, Gong, L et al. (9 more authors) (2018) Cbl Ubiquitin Ligases Control B Cell Exit from the Germinal-Center Reaction. Immunity, 48 (3). 530-541.e6. ISSN 1074-7613

Mace, EM, Bigley, V, Gunesch, JT et al. (30 more authors) (2017) Biallelic mutations in IRF8 impair human NK cell maturation and function. Journal of Clinical Investigation, 127 (1). pp. 306-320. ISSN 0021-9738

Manka, P, Coombes, JD, Boosman, R et al. (3 more authors) (2018) Thyroid hormone in the regulation of hepatocellular carcinoma and its microenvironment. Cancer Letters, 419. pp. 175-186. ISSN 0304-3835

Md Yusof, MY, Vital, EM, Das, S et al. (5 more authors) (2015) Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions. Annals of the Rheumatic Diseases, 74 (9). pp. 1734-1738. ISSN 0003-4967

Milanovic, M, Heise, N, De Silva, NS et al. (6 more authors) (2017) Differential requirements for the canonical NF-κB transcription factors c-REL and RELA during the generation and activation of mature B cells. Immunology and Cell Biology, 95 (3). pp. 261-271. ISSN 0818-9641

Munir, T, Howard, DR, McParland, L et al. (12 more authors) (2017) Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL. Leukemia, 31 (10). pp. 2085-2093. ISSN 0887-6924

Norris, K, Hillmen, P, Rawstron, A et al. (4 more authors) (2019) Telomere length predicts for outcome to FCR chemotherapy in CLL. Leukemia, 33 (8). pp. 1953-1963. ISSN 0887-6924

Oh, H, Grinberg-Bleyer, Y, Liao, W et al. (11 more authors) (2017) An NF-κB Transcription-Factor-Dependent Lineage-Specific Transcriptional Program Promotes Regulatory T Cell Identity and Function. Immunity, 47 (3). 450-465.e5. ISSN 1074-7613

Painter, D, Barrans, S, Lacy, S et al. (8 more authors) (2019) Cell‐of‐origin in diffuse large B‐cell lymphoma: findings from the UK's population‐based Haematological Malignancy Research Network. British Journal of Haematology, 185 (4). pp. 781-784. ISSN 0007-1048

Papa, S and Bubici, C (2018) Feeding the Hedgehog: A new meaning for JNK signalling in liver regeneration. Journal of Hepatology, 69 (3). pp. 572-574. ISSN 0168-8278

Papa, S and Bubici, C (2016) Linking apoptosis to cancer metabolism: Another missing piece of JuNK. Molecular & Cellular Oncology, 3 (2). e1103398. ISSN 2372-3556

Papa, S, Choy, PM and Bubici, C (2019) The ERK and JNK pathways in the regulation of metabolic reprogramming. Oncogene, 38 (13). pp. 2223-2240. ISSN 0950-9232

Parrish, C, Scott, GB, Migneco, G et al. (13 more authors) (2015) Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia. Leukemia, 29 (9). 1799 - 1810. ISSN 0887-6924

Peacock-Young, B, Macrae, FL, Newton, DJ et al. (2 more authors) (2018) The prothrombotic state in paroxysmal nocturnal hemoglobinuria: a multifaceted source. Haematologica, 103 (1). pp. 9-17. ISSN 0390-6078

Rawstron, AC, Kreuzer, K-A, Soosapilla, A et al. (30 more authors) (2018) Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project. Cytometry Part B: Clinical Cytometry, 94 (1). pp. 121-128. ISSN 1552-4949

Rawstron, AC, Ssemaganda, A, de Tute, R et al. (11 more authors) (2017) Monoclonal B-cell lymphocytosis in a hospital-based UK population and a rural Ugandan population: a cross-sectional study. Lancet Haematology, 4 (7). e334-e340. ISSN 2352-3026

Riemann, M, Andreas, N, Fedoseeva, M et al. (7 more authors) (2017) Central immune tolerance depends on crosstalk between the classical and alternative NF-κB pathways in medullary thymic epithelial cells. Journal of Autoimmunity, 81. pp. 56-67. ISSN 0896-8411

Robak, T, Burger, JA, Tedeschi, A et al. (23 more authors) (2018) Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies. American Journal of Hematology, 93 (11). pp. 1402-1410. ISSN 0361-8609

Robbe, P., Ridout, K.E., Vavoulis, D.V. et al. (142 more authors) (2022) Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features. Nature Genetics, 54. pp. 1675-1689. ISSN 1061-4036

Roberts, NA, Adams, BD, McCarthy, NI et al. (5 more authors) (2017) Prdm1 Regulates Thymic Epithelial Function To Prevent Autoimmunity. The Journal of Immunology, 199 (4). pp. 1250-1260. ISSN 0022-1767

Robinson, E, Care, M, Tooze, R et al. (1 more author) (2018) Salt-Inducible kinases are critical regulators of terminal B-cell differentiation. Journal of Immunology, 200 (1). Supplement 171.3. ISSN 0022-1767

Ryan, CE, Sahaf, B, Logan, AC et al. (13 more authors) (2016) Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT. Blood, 128 (25). pp. 2899-2908. ISSN 0006-4971

Salakhieva, DV, Sadreev, II, Chen, MZQ et al. (4 more authors) (2016) Kinetic regulation of multi-ligand binding proteins. BMC Systems Biology, 10. 32.

Savic, S, Ouboussad, L, Dickie, LJ et al. (10 more authors) (2014) TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes. Journal of Autoimmunity, 50. pp. 59-66. ISSN 0896-8411

Seymour, JF, Kipps, TJ, Eichhorst, B et al. (17 more authors) (2018) Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia. New England Journal of Medicine, 378 (12). pp. 1107-1120. ISSN 0028-4793

Sha, C, Barrans, S, Care, MA et al. (4 more authors) (2015) Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas. Genome Medicine: medicine in the post-genomic era, 7. 64. ISSN 1756-994X

Sha, C, Barrans, S, Cucco, F et al. (20 more authors) (2019) Molecular high-grade B cell lymphoma: defining a poor risk group requiring different approaches to therapy. Journal of Clinical Oncology, 37 (3). pp. 202-213. ISSN 0732-183X

Sinfield, JK, Das, A, Ball, SG et al. (3 more authors) (2013) P38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts. Biochemical and Biophysical Research Communications, 430 (1). 419 - 424. ISSN 0006-291X

Socie, G, Caby-Tosi, M-P, Marantz, JL et al. (7 more authors) (2019) Eculizumab in paraxysmal nocturnal haemogloburinia and atypical haemolytic syndrome 10-year pharmacovigilance analysis. British Journal of Haematology, 185 (2). pp. 297-310. ISSN 0007-1048

Stephenson, S, Care, MA, Fan, I et al. (4 more authors) (2019) Growth factor-like gene regulation is separable from survival and maturation in antibody secreting cells. Journal of Immunology, 202 (4). pp. 1287-1300. ISSN 0022-1767

Thorne, JL, Ouboussad, L and Lefevre, PF (2012) Heterochromatin protein 1 gamma and IiB kinase alpha interdependence during tumour necrosis factor gene transcription elongation in activated macrophages. Nucleic Acids Research, 40 (16). pp. 7676-7689. ISSN 0305-1048

Varghese, A, Howard, DR, Pocock, C et al. (9 more authors) (2017) Eradication of minimal residual disease improves overall and progression free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: A Phase II trial assessing alemtuzumab consolidation. British Journal of Haematology, 176 (4). pp. 573-582. ISSN 0007-1048

Varghese, AM, Rawstron, A, Newton, D et al. (5 more authors) (2018) Highly selective SYK inhibitor, GSK143, abrogates survival signals in chronic lymphocytic leukaemia. British Journal of Haematology, 182 (6). pp. 927-930. ISSN 0007-1048

Verzella, D, Bennett, J, Fischietti, M et al. (17 more authors) (2018) GADD45β Loss Ablates Innate Immunosuppression in Cancer. Cancer Research, 78 (5). pp. 1275-1292. ISSN 0008-5472

Vrzalikova, K, Ibrahim, M, Vockerodt, M et al. (19 more authors) (2017) S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells. Leukemia, 32. pp. 214-223. ISSN 0887-6924

Walker, CR, Hautefort, I, Dalton, JE et al. (7 more authors) (2013) Intestinal intraepithelial lymphocyte-enterocyte crosstalk regulates production of bactericidal angiogenin 4 by Paneth cells upon microbial challenge. PLoS ONE, 8 (12). e84553. ISSN 1932-6203

Worrillow, L, Baskaran, P, Care, MA et al. (9 more authors) (2016) An ultra-deep sequencing strategy to detect sub-clonal TP53 mutations in presentation chronic lymphocytic leukemia cases using multiple polymerases. Oncogene, 35 (40). pp. 5328-5336. ISSN 0950-9232

de Tute, RM, Pawlyn, C, Cairns, DA et al. (14 more authors) (2022) Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk. Journal of Clinical Oncology, 40 (25). pp. 2889-2900. ISSN 0732-183X

Book Section

Heise, N and Klein, U (2017) Somatic hypermutation and affinity maturation analysis using the 4-hydroxy-3-nitrophenyl-acetyl (NP) system. In: Calado, DP, (ed.) Germinal Centers. Methods in Molecular Biology, 1623 . Springer (Humana) , pp. 191-208. ISBN 978-1-4939-7094-0


Howard, DR, Munir, T, McParland, L et al. (9 more authors) (2017) Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial. Report. National Institute for Health Research , Health Technology Assessment. ISSN 1366-5278

Conference or Workshop Item

Rawstron, A, Cohen, D, de Tute, R et al. (8 more authors) (2015) BONE MARROW IS MORE SENSITIVE THAN PERIPHERAL BLOOD FOR DETECTION OF MRD IN CLL AND PROVIDES A MORE RELIABLE PREDICTION OF OUTCOME ACROSS DIFFERENT TREATMENTS. In: European Haematology Association Congress, 11-14 Jun 2015, Vienna, Austria.

Proceedings Paper

Briones, MA, Coombes, JD, Mellone, M et al. (12 more authors) (2016) The role of osteopontin isoforms in cholangiocarcinoma. In: Hepatology. The 67th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2016, 11-15 Nov 2016, Massachusetts, United States. Wiley , 235A-235A.

Briones-Orta, MA, Coombes, JD, Mellone, M et al. (11 more authors) (2015) Osteopontin‐c isoform promotes a mesenchymal phenotype in human cholangiocarcinoma cells. In: Hepatology. 66th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2015, 13-17 Nov 2015, San Francisco, CA, USA. Wiley , 1171A-1171A.

Burger, J, Tedeschi, A, Barr, PM et al. (32 more authors) (2016) International, randomized phase 3 study results: Ibrutinib versus Chlorambucil in patients 65 years and older with treatment-naive CLL (RESONATE-2 (TM)). In: Oncology Research and Treatment. Annual conference of the German, Austrian and Swiss Societies for Haematology and Medical Oncology, 14-18 Oct 2016, Leipzig, Germany. Karger Publishers , p. 6.

Choy, PM, Sufi, J, Glaser, S et al. (7 more authors) (2015) Inhibition of mapk signalling promotes cell cycle arrest and sensitises intrahepatic cholangiocarcinoma cells to chemotherapy. In: Gut. 2nd Digestive Disorders Federation Conference, 22-25 Jun 2015, London, UK. BMJ Publishing Group , A458-A458.

Cullen, M, Richards, S, Bowen, D et al. (3 more authors) (2017) The Application of Machine Learning Algorithms to Immunophenotypic Data to Aid in the Diagnosis of MDS. In: Leukemia Research. The 14th International Symposium of Myelodysplastic Syndromes (MDS), 03-06 May 2017, Valencia, Spain. Elsevier Ltd. , S95-S95.

Holmes, K, Lefevre, P, Sadreev, I et al. (4 more authors) (2017) Ibrutinib mediates changes in chromatin structure in chronic lymphocytic leukaemia (CLL): epigenetic studies from the bloodwise TAP IcICLLe trial. In: Leukemia and Lymphoma. XVII International Workshop on Chronic Lymphocytic Leukemia, 12-15 May 2017, New York, USA. Taylor and Francis , pp. 19-20.

Iansante, V, Choy, PM, Chokshi, S et al. (4 more authors) (2015) Addressing the interplay between apoptosis and glucose metabolism in liver cirrhosis and HCC. In: Gut. 2nd Digestive Disorders Federation Conference, 22-25 Jun 2015, London, UK. BMJ Publishing Group , A12-A12.

Iansante, V, Choy, PM, Chokshi, S et al. (4 more authors) (2015) Increased aerobic glycolysis is associated with poor outcome and suppression of apoptosis in human liver cirrhosis and HCC. In: Journal of Hepatology. The International Liver Congress 2015: 50th Annual meeting of the European Association for the Study of the Liver, 22-26 Apr 2015, Vienna, Austria. Elsevier , S427-S427.

Iansante, V, Choy, PM, Fung, SW et al. (8 more authors) (2014) Upregulation of a novel protein in HCC enhances cancer cell survival by suppressing specific apoptotic effectors. In: Journal of Hepatology. The International Liver Congress 2014 – 49th Annual meeting of the European Association for the Study of the Liver, 09-13 Apr 2014, London, UK. Elsevier , S89-S89.

Macrae, F, Bowman, P, Linton, E et al. (13 more authors) (2017) Fibrinogen and Clot Structure Is Affected By Eculizumab in Patients with Paroxysmal Nocturnal Haemoglobinuria. In: Blood. 59th Annual Meeting of the American-Society-of-Hematology, 09-12 Dec 2017, Atlanta, GA. American Society of Hematology , p. 462.

Papa, S, Lee, N and Bubici, C (2018) Deciphering preventive and prognostic biomarkers of liver cancer. In: NCRI Cancer Conference abstracts. NCRI Cancer Conference 2018, 04-06 Nov 2018. NCRI .

Peffault De Latour, R, Mitchell, L, Brodsky, RA et al. (10 more authors) (2019) Ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: pharmacokinetics and pharmacodynamics observed in two Phase 3 randomized, multicenter studies. In: British Journal of Haematology. 59th Annual Scientific Meeting of the British Society for Hematology, 01-03 Apr 2019, Glasgow, UK. Wiley , p. 110.

This list was generated on Mon Apr 22 03:54:22 2024 BST.